Results 271 to 280 of about 177,468 (356)
Aberrant immunophenotypic expressions in childhood acute leukemias: A tertiary care hospital experience. [PDF]
Saqlain N+3 more
europepmc +1 more source
EXPRESSION OF HLA ANTIGENS ON RENAL TUBULAR CELLS IN CULTURE
G. Alex Bishop+5 more
openalex +1 more source
Abstract Chronic histiocytic intervillositis (CHI) is an inflammatory condition of the placenta, characterised by an abnormal, mainly macrophagic infiltrate within the intervillous space. Recent research suggests that CHI results from a ‘maternal‐foetal rejection’ mechanism, because at least some CHI cases fulfil the criteria for antibody‐mediated ...
Léonie Albersammer+18 more
wiley +1 more source
A naturally selected αβ T cell receptor binds HLA-DQ2 molecules without co-contacting the presented peptide. [PDF]
Lim JJ+7 more
europepmc +1 more source
A Tc1‐ and Th1‐T‐lymphocyte‐rich tumor microenvironment is a hallmark of MSI colorectal cancer
Abstract Microsatellite instability is a strong predictor of response to immune checkpoint therapy and patient outcome in colorectal cancer. Although enrichment of distinct T‐cell subpopulations has been determined to impact the response to immune checkpoint therapy and patient outcome, little is known about the underlying changes in the composition of
Zhihao Huang+30 more
wiley +1 more source
Leveraging mRNA technology for antigen based immuno-oncology therapies. [PDF]
Floudas CS+3 more
europepmc +1 more source
ABSTRACT Background L‐asparaginase is essential in treating pediatric acute lymphoblastic leukemia (ALL) but is limited by hypersensitivity reactions in up to 70% of patients, leading to severe, dose‐limiting complications and compromised event‐free survival. Procedure This study conducted a genome‐wide association study (GWAS) in a discovery cohort of
Spencer J. Anderson+10 more
wiley +1 more source
Multi-targeted, NOT gated CAR-T cells as a strategy to protect normal lineages for blood cancer therapy. [PDF]
DiAndreth B+16 more
europepmc +1 more source
ABSTRACT Background Allogeneic hematopoietic stem cell transplantation (HSCT) is challenged by endothelial dysfunction‐related syndromes like sinusoidal obstruction syndrome (SOS), capillary leak syndrome (CLS), and severe acute graft‐versus‐host disease (aGvHD). We investigated soluble thrombomodulin (sTM), an endothelial damage marker, in relation to
Denise Elbæk Horan+5 more
wiley +1 more source